Guest guest Posted September 27, 2006 Report Posted September 27, 2006 Someone asked if these two products can now be used together via the respective expanded access programs. The answer is no. Merck is still performing interaction studies to see if these two drugs can be combined without dose adjustment. They will let me know when that data are available. Most people can use MRK 518 with either Fuzeon, Prezista, or Aptivus, plus a background of nucleosides like Combivir, Truvada, or Epzicom. Non nukes like Viramune and Sustiva may also be used. Merck will be presenting their treatment experience data from their phase II this Friday at ICAAC (I am in San Francisco now at that conference). I am sure Jules will be sending out that info as soon as it is presented. It looks extremely good with a large proportion of salvage patients achieving undetectable viral loads, even without an active drug in their background. Regards, Vergel powerusa dot org Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.